EPHA2 and lung cancer: In vitro, EphA2-TEA-VV not only lysed infected tumor cells, but also induced bystander killing of noninfected tumor cells when in the presence of T cells.66 In a lung cancer xenograft model, EphA2-TEA-VV-infected T cells had potent antitumor activity compared with control VV-infected T cells.